Sellas Life Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 292 | -6,601 | -6,063 | -16,382 |
EBIT | -6,791 | -6,873 | -6,063 | -6,737 |
Net Income | -6,791 | -6,601 | -5,813 | -6,737 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,068 | -7,330 | -9,070 | -7,153 |
Cash | 44,420 | 25,297 | 28,397 | 13,886 |
Basic Shares | 108,396 | 98,558 | 87,760 | 612,024 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,000 | $7,600 |
Gross Profit | 0 | 900 | 7,400 | |
EBITDA | 632 | 529 | -31,493 | -18,321 |
EBIT | -30,881 | -37,340 | -31,950 | -19,594 |
Net Income | -30,881 | -37,340 | -41,301 | -20,699 |
Net Change In Cash | 0 | 0 | 1,000 | 7,600 |
Free Cash Flow | -35,402 | -36,910 | -28,309 | -26,021 |
Cash | 13,886 | 2,530 | 17,125 | 21,455 |
Basic Shares | 612,024 | 249,994 | 19,396 | 15,481 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.07 |
2025-03-31 | -$0.07 |
